Mobile

A Multi-centre, Double-blind, Double-Dummy, Placebo-controlled, Parallel Group, Randomised, Phase IIb Proof of Concept Study with 3 oral dose groups of AZD3480 or donepezil during 12 weeks treatment i...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-000835-24

A Multi-centre, Double-blind, Double-Dummy, Placebo-controlled, Parallel Group, Randomised, Phase IIb Proof of Concept Study with 3 oral dose groups of AZD3480 or donepezil during 12 weeks treatment in patients with Alzheimer’s Disease Estudio en fase IIB, multicéntrico, doble ciego, controlado con placebo, de grupos paralelos y aleatorizado, de tratamiento con 3 dosis orales de AZD3480 o donepezilo durante 12 semanas en pacientes con enfermedad de Alzheimer. Prueba de concepto

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To prove the concept that AZD3480 improves cognition in Alzheimer's disease patients in relation to placebo and donepezil, assessed as change from baseline on Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog).

Critère d'inclusion

  • Alzheimer's Disease
  • Enfermedad de Alzheimer

Liens